Analysis of additive effects of rivaroxaban added to plasma of patients treated with vitamin-K antagonists

被引：0
|
作者：
Harenberg, J. [1 ]
Giese, C. [1 ]
Marx, S. [1 ]
Weiss, C. [2 ]
Kraemer, R. [3 ]
机构：
[1] Univ Med Mannheim, Mannheim, Germany
[2] Fac Med Mannheim, Dept Biometry & Biomed Stat, Mannheim, Germany
[3] Heidelberg Univ, Inst Inorgan Chem, D-69115 Heidelberg, Germany
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-TU-179
引用
收藏
页码：365 / 365
页数：1
相关论文
共 50 条
  • [41] THE ANTIBACTERIAL EFFECTS OF ANALOGUES OF VITAMIN-K
    ATKINS, P
    WARD, JL
    BRITISH JOURNAL OF EXPERIMENTAL PATHOLOGY, 1945, 26 (02): : 120 - 124
  • [42] Heavy menstrual bleeding in women treated with rivaroxaban and vitamin K antagonists and the risk of recurrent venous thromboembolism
    Bryk, Agata Hanna
    Pirog, Magdalena
    Plens, Krzysztof
    Undas, Anetta
    VASCULAR PHARMACOLOGY, 2016, 87 : 242 - 247
  • [43] ATRIAL FIBRILLATION TREATMENT PARADOX: CHARACTERISTICS OF AND FIRST-YEAR EVENTS IN PATIENTS NOT TREATED WITH VITAMIN-K ANTAGONISTS COMPARED TO TREATED PATIENTS. THE GARFIELD REGISTRY
    Bassand, Jean-Pierre L.
    Rushton-Smith, Sophie
    Camm, A. John
    Goldhaber, Samuel Z.
    Goto, Shinya
    Haas, Sylvia
    Mueller, Iris
    Turpie, Alexander G.
    Kakkar, Ajay
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E379 - E379
  • [44] Rivaroxaban or vitamin-K antagonists following early endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis
    Sebastian, Tim
    Hakki, Lawrence O.
    Spirk, David
    Baumann, Frederic A.
    Periard, Daniel
    Banyai, Martin
    Spescha, Rebecca S.
    Kucher, Nils
    Engelberger, Rolf P.
    THROMBOSIS RESEARCH, 2018, 172 : 86 - 93
  • [45] UNSUSPECTED SOURCE OF VITAMIN-K IN PATIENTS TREATED WITH ANTICOAGULANTS - A CASE-REPORT
    OREN, B
    SHVARTZMAN, P
    FAMILY PRACTICE, 1989, 6 (02) : 151 - 152
  • [46] CEREBRAL THROMBOSIS IN 2 PATIENTS WITH MALABSORPTION-SYNDROME TREATED WITH VITAMIN-K
    FLORHOLMEN, J
    WALDUM, H
    NORDOY, A
    BRITISH MEDICAL JOURNAL, 1980, 281 (6239): : 541 - 541
  • [47] Rivaroxaban Use in Patients with Antiphospholipid Syndrome Patients and Previous Poor Anticoagulation Control with Vitamin K Antagonists
    Sciascia, Savino
    Hunt, Beverley
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S7 - S7
  • [48] The effects of vitamin K-antagonists on survival of patients with malignancy:: A systematic analysis
    Smorenburg, SM
    Vink, R
    Otten, HM
    Swaneveld, F
    Büller, HR
    THROMBOSIS AND HAEMOSTASIS, 2001, 86 (06) : 1586 - 1587
  • [49] Which patients would be willing to change anticoagulation with vitamin-K antagonists to a new oral anticoagulant
    Harenberg, J.
    Abou-Ayash, N.
    Marx, S.
    Hoeing, V
    Schirk, K.
    Weiss, C.
    Froelich, L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 110 - 110
  • [50] The procoagulant effect of Vitamin-K antagonists in patients with atrial fibrillation, atherosclerosis and deep venous thrombosis
    Al Dieri, R.
    ten Cate-Hoek, A. J.
    ten Cate, H.
    Hemker, H. C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 857 - 857
12345